<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr stylecode="Botrule">
<td align="center" stylecode="Lrule Rrule" valign="top"> <br/>
<content stylecode="bold">Drug or Drug Class</content>
<br/> <br/>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top"> <br/>
<content stylecode="bold">Effect</content>
<br/> <br/>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule" valign="top"> <br/>Beta-adrenergic antagonists <br/> <br/>   (e.g. Propranolol <br/>
<br/>        &gt; 160 mg/day)<br/>
<br/>
<br/>
</td>
<td align="left" stylecode="Rrule" valign="top"> <br/>In patients treated with large doses of propranolol (&gt; 160 mg/day), T<sub>3</sub> and T<sub>4</sub> levels change slightly, TSH levels remain normal, and patients are clinically euthyroid.  It should be noted that actions of particular beta-adrenergic antagonists may be impaired when the hypothyroid patient is converted to the euthyroid state. <br/> <br/>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule" valign="top"> <br/>Glucocorticoids <br/> <br/>      (e.g.     <br/>                    Dexamethasone <br/>
<br/>          ≥ 4 mg/day)<br/>
<br/> <br/>
<br/>
<br/>
</td>
<td align="left" stylecode="Rrule" valign="top"> <br/>Short-term administration of large doses of glucocorticoids may decrease serum T<sub>3</sub> concentrations by 30% with minimal change in serum T<sub>4</sub> levels.  However, long-term glucocorticoid therapy may result in slightly decreased T<sub>3</sub> and T<sub>4</sub> levels due to decreased TBG production (see above).<br/> <br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode="Lrule Rrule" valign="top"> <br/>Other drug:<br/> <br/>Amiodarone<br/>
<br/>
<br/>
</td>
<td align="left" stylecode="Rrule" valign="top"> <br/>
</td>
</tr>
</tbody>
</table>